Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain

Clinical Journal of Pain

Volumn 18, Issue 6, 2002, Pages 355-365

  Turk, Dennis C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Anticonvulsants; Antidepressants; Implantable drug delivery systems; Opioids; Pain rehabilitation program; Spinal cord stimulation

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; OPIATE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT;

CHRONIC PAIN; CONSERVATIVE TREATMENT; COST EFFECTIVENESS ANALYSIS; DISABILITY; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOLERANCE; EVALUATION; FUNCTIONAL ASSESSMENT; HEALTH CARE UTILIZATION; HUMAN; NEUROTOXICITY; OUTCOMES RESEARCH; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; REVIEW; SPINAL CORD;

CHRONIC DISEASE; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; PAIN; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 0036844652     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200211000-00003     Document Type: Review

References (75)

1. Verhaak PFM, Kerssens JJ, Dekker J, et al. Prevalence of chronic benign pain disorder among adults: A review of the literature. Pain 1998;77:231-9.
2. Volinn E. The epidemiology of low back pain in the rest of the world. A review of surveys in low- and middle-income countries. Spine 1997;22:1747-54.
3. Frolund F, Frolund C. Pain in general practice. Scand J Primary Healthcare 1986;4:97-100.
4. Lousberg R. Chronic Pain. Multiaxial Diagnostics and Behavioral Mechanisms. Maastricht: University of Maastricht, 1994 (thesis).
5. Elliott AM, Smith BH, Penny KI, et al. The epidemiology of chronic pain in the community. Lancet 1999;354:1248-52.
6. Blyth FM, March LM, Brnabic AJM, et al. Chronic pain in Australia: A prevalence study. Pain 2001;89:127-34.
7. National Assembly for Wales. Welsh Health Survey. Cardiff: Government Statistical Service, 1999.
8. Beregman S, Herrstrom P, Hogstrm K. et al. Chronic musculoskeletal pain, prevalence rates and sociodemographic associations in a Swedish population study. J Rheumatol 2001;28:1369-77.
9. Back Care, 2001. Available at: http://www.back pain.org/pr-facts.htm.
10. Stang P, Von Korff M, Galer BS. Reduced labor force participation among primary care patients with headache. J Gen Intern Med 1998;13:296-302.
11. Gureje O. Persistent pain and well-being: A World Health Organization study in primary care. JAMA 1998;280:147-51.
12. Marketdata Enterprises. Chronic Pain Management Programs: A Market Analysis. Valley Stream, NY: Marketdata Enterprises, 1995.
13. Cousins MJ. Foreword. In: Fordyce WE, ed. Back Pain in the Workplace: Management of Disability in Nonspecific Conditions. Task Force Report. Seattle: IASP Press, 1995, p. ix.
14. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain 2000;84:95-103.
15. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: Disability and economic costs. Arch Intern Med 1999;159:813-8.
16. De Lissovoy G, Brown RE, Halpern M, et al. Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. Clin Ther 1997;19:96-112.
17. Frymoyer J, Durett C. The economics of spinal disorders. In: Frymoyer J, ed. The Adult Spine. Philadelphia: Lippincott-Raven, 1997:143-150.
18. Lubeck PA. Review of the direct costs of rheumatoid arthritis. Pharmacoeconomics 2001;19:811-8.
19. Buchbinder R, Jolley D, Wyatt M. Population-based intervention to change back pain beliefs and disability: Three-part evaluation. BMJ 2001;322:1516-20.
20. Simmons J, Avant W, Demski J, et al. Determining successful pain clinic treatment through validation of cost effectiveness. Spine 1988;13:24-34.
21. Bell G, Kidd D, North R. Cost-effectiveness analysis of spinal cord stimulation in treatment of failed back surgery syndrome. J Pain Symp Manage 1997:13:286-95.
22. Red Book. Drug Topics. Top 200 Brand-Name Drugs by Prescription. Montvale, NJ: Medical Economics. March 6, 2002.
23. Straus BN. Chronic benign pain syndromes - The cost of intervention. Spine: in press.
24. National Center for Health Statistics. 1997 National Hospital Discharge Survey. Series 13, no. 144. Washington, DC: U.S. Dept. of Health and Human Services, Center for Disease Control, 1997.
25. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers; a meta-analytic review. Pain 1992;49:221-30.
26. Segal R, Stacey BR. Spinal cord stimulation revisited. Neurol Res 1998;20:391-6.
27. Krames ES, Olson K. Clinical realities and economic considerations: Patient selection in intrathecal therapy. J Pain Symptom Manage 1997;14(Suppl):S3-13.
28. Schappert SM. Ambulatory Care Visits to Physicians Offices, Hospital Outpatient Departments, and Emergency Departments: United States, 1996. Vital and Health Statistics, series 13 (134), 1998;1-80.
29. National Center for Health Statistics. National Ambulatory Medical Care Survey, 1998. Washington. DC: U.S. Dept. of Health and Human Services, 1998.
30. Ref. deleted during editing.
31. Turk DC, Loeser JD, Monarch ES. Chronic pain: Purposes and costs of interdisciplinary pain rehabilitation programs. TEN: Cost Neurosci; in press.
32. Dworkin RH, Allen RR, Argoff CR, et al. Guidelines for the Pharmacologic Management of Chronic Neuropathic Pain. Submitted for publication.
33. Collins SL, Moore A, McQuay HJ, et al. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J Pain Symptom Manage. 2000;20:449-58.
34. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-27.
35. Dvorak J, Gauchat M, Valach L. The outcome of surgery for lumbar disc herniation: I. A 4-17 years' follow-up with emphasis on somatic aspects. Spine 1988;13:1418-22.
36. Franklin GM, Haug J, Heyer NJ, et al. Outcome of lumbar fusion in Washington State Workers' Compensation. Spine 1994;19:1897-904.
37. Lehmann TR, Spratt KF, Tozzi JE, et al. Long-term follow up of lower lumbar fusion patients. Spine 1987;12:97-104.
38. North RG, Ewend MG, Lawton MT, et al. Failed back surgery syndrome: 5-Year follow-up after spinal cord stimulator implantation. Neurosurgery 1991;28:692-9.
39. North RB, Kidd DH, Zahurak M, et al. Spinal cord stimulation for chronic, intractable pain: Experience over two decades. Neurosurgery 1993;32:384-94.
40. Turner JA, Loeser JD, Bell KG. Spinal cord stimulation for chronic low back pain: A systematic literature synthesis. Neurosurgery 1995;37:1088-96.
41. Van Buyten J-P, Van Zundert J, Vueghs P, et al. Efficacy of spinal cord stimulation: 10 Years of experience in a pain center in Belgium. Eur J Pain 2001;5:259-307.
42. Burchiel KJ, Anderson VC, Brown FD, et al. Prospective, multicenter study of spinal cord stimulator for relief of chronic back and extremity pain. Spine 1996;21:2786-94.
43. Farrar JT, Portenoy RK, Berlin JA, et al. Defining the clinically important difference in pain outcome measures. Pain 2000;88:287-94.
44. Hassenbusch SJ, Stanton-Hicks MD, Soukup J, et al. Sufentanil citrate and morphine/bupivacaine as alternative agents in chronic epidural infusions for intractable noncancer pain. Neurosurgery 1991;29:76-82.
45. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: A retrospective, multicenter study. J Pain Symptom Manage 1996;11:71-80.
46. Kumar K, Kelly M, Pirlot T. Continuous intrathecal morphine treatment of chronic pain of nonmalignant etiology: Long-term benefits and efficacy. Surg Neurol 2001;55:79-88.
47. Hassenbusch SJ, Stanton-Hicks M, Covington EC, et al. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995:10:527-43.
48. Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999;44:289-301.
49. Guzman J, Esmail R, Karjalainenen K, et al. Multidisciplinary rehabilitation for chronic low back pain: Systematic review. BMJ 2001;7301:1511-5.
50. Morley S, Eccleston, C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy and behavior therapy for chronic pain in adults, excluding headache. Pain 1999;80:1-13.
51. Ohnmeiss DD, Rashbaum RF, Boddanffy GM. Prospective evaluation of spinal cord stimulation in patients with intractable leg pain. Spine 1996;21:1344-51.
52. Kumar K, Nath R, Wyatt GM. Treatment of chronic pain by epidural spinal cord stimulation: A 10-year experience. J Neurosurg 1991;75:402-7.
53. Doleys D, Coleton M, Tutak U. Use of intraspinal infusion therapy with non-cancer pain patients: Follow up and comparison of worker's compensation vs. non-worker's compensation patients. Neuromodulation 1998;1:149-59.
54. Breivik H. Opioids in cancer and chronic non-cancer pain therapy - Indications and controversies. Acta Anesthesiol Scand 2001;45:1059-66.
55. Malter AD, McNeney B, Loeser JD, et al. 5-Year reoperation rates after different types of lumbar spine surgery. Spine 1998;23:814-20.
56. Long DM, Filtzer DL, BenDebba M, et al. Clinical features of the failed-back syndrome. J Neurosurg 1988;69:61-71.
57. Friedlieb O. The impact of managed care of the diagnosis and treatment of low back pain: A preliminary report. Am J Med Qual 1994;9:24-9.
58. Turk DC. Clinician attitudes about prolonged use of opioids and the issue of patient heterogeneity. J Pain Symptom Manage 1996;11:218-30.
59. Sindrup S, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999;83:389-400.
60. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000;55:915-20.
61. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 2001;18:22-7.
62. McQuay H, Carrol D, Jadad AR, et al. Anticonvulsant drugs for management of pain: A systematic review. BMJ 1995;311:1047-52.
63. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997;73:123-39.
64. Prager JP. Neuraxial medication delivery: The development and maturity of a concept for treating pain associated with failed back surgery syndrome. Spine; in press.
65. Gallon R, Perception of disability in chronic back pain patients: A long-term follow up. Pain 1989;37:67-75.
66. Turk DC. Transition from acute to chronic pain: role of demographic and psychosocial factors. In: Jensen TS, Turner JA, Wiesenfeld-Hallin Z, eds. Proceedings of the Eighth World Congress on Pain: Progress in Pain Research and Management. Seattle: IASP Press, 1997:185-213.
67. Leclaire R, Fortin L, Lambert R, et al. Radiofrequency facet joint denervation in the treatment of low back pain: A placebo-controlled clinical trial to assess efficacy. Spine 2001;26:1411-6.
68. Kupers R, Van den Oever R, Van Houdenhove B, et al. Spinal cord stimulation in Belgium: A nation-wide survey on the incidence, indications and therapeutic efficacy by the health insurer. Pain 1996;56:211-7.
69. Thomsen A, Sorensen J, Sjogren P, et al. Chronic non-malignant pain patients and health economic consequences. Eur J Pain 2002;6:341.
70. Stieg RL, Turk DC. Chronic pain syndrome: The necessity of demonstrating the cost-benefit of treatment. Pain Manage 1988;1:58-63.
71. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: A diathesis-stress framework. Psychol Bull 1996;119:95-110.
72. Von Korff M, Dworkin S, LeResche L, et al. Epidemiology of temporomandibular disorders: II, TMD pain compared with other common pain sites. In: Dubner R, Gebhart G, Bond M, eds. Proceedings of the Fifth World Congress on Pain. Amsterdam: Elsevier, 1988:506-11.
73. Crook J, Tunks E, Rideout E, et al. Epidemiologic comparison of persistent pain sufferers in a specialty pain clinic and in the community. Arch Phys Med Rehabil 1986;67:451-5.
74. Crook J, Weir R, Tunks E. An epidemiologic follow-up survey of persistent pain sufferers in a group family practice and specialty pain clinic. Pain 1989;36:49-61.
75. Weir R, Browne GB, Tunks E, et al. A profile of users of specialty pain clinic services: Predictors of use and cost estimates. J Clin Epidemiol 1992;45:1399-415.